Scimega

Scimega is a Canadian niche CRO specializing exclusively in oncology clinical trials. With over 25 years of experience, it has supported more than 100 successful oncology studies across Canada. The company’s unique value lies in its deep relationships with Canadian research sites and investigators, enabling faster trial start-up times—reportedly up to 50% quicker than industry averages. Its proprietary Reverse Feasibility Program connects sponsors with top-performing Canadian investigators to accelerate patient recruitment and site activation. The company does not develop its own therapeutics but provides critical services to small and mid-sized biopharma companies seeking efficient entry into the Canadian market for their cancer drug candidates.